Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01/06/18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
Mostafa Abuzeid
PRN | Corporate Officer/Principal | - | - |
Hans Christinger
PRN | Corporate Officer/Principal | - | - |
Gilbert Jaoudé
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 3 204 401 | 2 483 540 ( 77,50 %) | 0 | 77,50 % |
Información de la empresa
Innovus Pharmaceuticals, Inc.
373 Inverness Parkway Suite 206
80112, Englewood
+858-964-5123
http://www.innovuspharma.comVaria. 1 de ene. | Capi. | |
---|---|---|
+37,74 % | 723 mil M | |
+34,21 % | 595 mil M | |
-2,07 % | 369 mil M | |
+20,25 % | 332 mil M | |
+2,99 % | 282 mil M | |
+17,06 % | 244 mil M | |
+9,80 % | 208 mil M | |
-4,38 % | 205 mil M | |
+2,81 % | 168 mil M |
- Bolsa de valores
- Acciones
- Acción
- Empresa Innovus Pharmaceuticals Inc